Buspirone Hydrochloride Tablet
Product Images NDC 71335-0222

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71335-0222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 01

FDA Label Image

3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 02

This is a guide to help patients divide their medication into smaller doses based on what their doctor prescribed. The text provides instructions on how to divide 15 mg and 30 mg tablets into halves, one-third and two-thirds doses. The information is presented in a table format with the amount of medication indicated next to different fractions of the tablet.*

FDA Label Image

3e7fdbd9 38d4 4315 A4b1 F2967fd6ed7b 03

FDA Label Image

Label Image (Lbl713350222)

This appears to be a label of a Buspirone HCI (a medication used to treat anxiety) container. The container has capsules of 10mg and tablets of 10mg. It also contains information on storing the capsules and tablets and preventing children from accessing them. The label has product and company identification codes such as "Cadila Healthcare Limited", "NDC 7133502221", and "03047301523487".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.